Amisulpride Versus Olanzapine Treatment for Behavioral and Psychological Symptoms in Patients With Dementia of the Alzheimer Type:A Randomized, Open-label, Prospective Study
Latest Information Update: 22 Nov 2022
Price :
$35 *
At a glance
- Drugs Amisulpride (Primary) ; Olanzapine
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- 15 Nov 2022 Planned End Date changed from 1 May 2023 to 1 May 2024.
- 15 Nov 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2023.
- 15 Oct 2021 Planned End Date changed from 1 May 2022 to 1 May 2023.